Skip to content

auriculotherapy and ADHD

Comparison of efficacy of auricular acupuncture with a control group in childhood with Attention-deficit/hyperactivity disorder

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090527001957N9
Enrollment
30
Registered
2019-09-30
Start date
2019-07-23
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

attention deficit hyperactivity disorder. Attention-deficit hyperactivity disorders

Interventions

Intervention 1: Intervention group: Acupuncture seeds are placed at the specific site of the disease and electrical stimulation is performed once a week for 4 weeks. In case of falling seed, stimulati

Sponsors

Research Institute for Islamic and Complementary Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: age 6-14 years diagnosis of ADHD based on DSM- V criteria informed consent of patients or their parents If medication, education, occupational and psychological therapy are used, there has been no change in drug dosage or treatment or symptoms of ADHD for at least the past 2 weeks.

Exclusion criteria

Exclusion criteria: History of epilepsy schizophrenia neurological disorders any psychological disorder requires medication hyperthyroidism

Design outcomes

Primary

MeasureTime frame
Severity of ADHD disorder. Timepoint: 1 and 3 weeks after intervention. Method of measurement: Caner's and CSI questionnaire.

Secondary

MeasureTime frame
Changes of the disease severity from the viewpoint of teachers. Timepoint: 3 weeks after intervention. Method of measurement: symptom severity checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFataneh Hashem-Dabaghian

Iran University of Medical Sciences

dabaghian.f@iums.ac.ir+98 21 3395 0154

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026